neostigmine methylsulfate
- Product NDC
- 31722-995
- 11-digit product format
- 317220995
- Labeler code
- 31722
- Product ID
- 31722-995_8265ddeb-9723-49af-85fa-0699c4c3c6d7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- neostigmine methylsulfate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Camber Pharmaceuticals Inc.
- Application
- ANDA212512
- Marketing category
- ANDA
- Marketing start
- 2021-01-04
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- neostigmine methylsulfate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NEOSTIGMINE METHYLSULFATE | 1 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 98IMH7M386 |
DailyMed Product Concepts#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 31722-995-31 | 31722099531 | 10 VIAL, MULTI-DOSE in 1 CARTON (31722-995-31) / 10 mL in 1 VIAL, MULTI-DOSE | 2021-01-04 | 0000-00-00 | No | No | Current |